These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. Peng X; Xu J; Arnér ES Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015 [TBL] [Abstract][Full Text] [Related]
3. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system. Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881 [TBL] [Abstract][Full Text] [Related]
4. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426 [TBL] [Abstract][Full Text] [Related]
5. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin. Prast-Nielsen S; Cebula M; Pader I; Arnér ES Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179 [TBL] [Abstract][Full Text] [Related]
6. Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift. Rigobello MP; Gandin V; Folda A; Rundlöf AK; Fernandes AP; Bindoli A; Marzano C; Björnstedt M Free Radic Biol Med; 2009 Sep; 47(6):710-21. PubMed ID: 19486940 [TBL] [Abstract][Full Text] [Related]
7. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073 [TBL] [Abstract][Full Text] [Related]
9. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia. Talbot S; Nelson R; Self WT Br J Pharmacol; 2008 Jul; 154(5):940-8. PubMed ID: 18587442 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of thioredoxin reductase 1 in human oral squamous cell carcinoma. Iwasawa S; Yamano Y; Takiguchi Y; Tanzawa H; Tatsumi K; Uzawa K Oncol Rep; 2011 Mar; 25(3):637-44. PubMed ID: 21206984 [TBL] [Abstract][Full Text] [Related]
12. [Effects of hnRNP B1 on DNA-PK activity, cell cycle and apoptosis in human lung adenocarcinoma cell line A549]. Han J; Li WM; Tang FM; Pu D; Chen WB Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):815-8. PubMed ID: 19024322 [TBL] [Abstract][Full Text] [Related]
13. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase. Xu J; Arnér ES Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931 [TBL] [Abstract][Full Text] [Related]
14. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770 [TBL] [Abstract][Full Text] [Related]
15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215 [TBL] [Abstract][Full Text] [Related]
16. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767 [TBL] [Abstract][Full Text] [Related]
18. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152 [TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase 1 upregulates MCP-1 release in human endothelial cells. Liu ZB; Shen X Biochem Biophys Res Commun; 2009 Sep; 386(4):703-8. PubMed ID: 19555664 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]